Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Phenetidine in Urine

Abstract

THE urinary substance referred to as B in a previous communication1 has now been isolated in pure form. It can be shown to be p-phenetidine by its infra-red and ultra-violet spectra, the melting point of a picrate (176–180° C.) and lack of depression of melting point in a mixture with authentic p-phenetidine picrate (179–181° C). It is present in urine as a labile acidic substance which can be precipitated by lead acetate and purified by paper chromatography from butanol–acetic acid (R F about 0.5). The precursor seems to be a conjugate with sulphuric acid. About 2–3 per cent of administered phenacetine is excreted in this form.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Špaček, M., Nature, 172, 204 (1953).

    Article  ADS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ŠPAČEK, M. Phenetidine in Urine. Nature 174, 933–934 (1954). https://doi.org/10.1038/174933b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/174933b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing